Strangnas

Researchers are evaluating a new person-centred and team-based approach to reduce inappropriate long-term opioid treatment (LTOT) and improve pain management for patients with chronic non-cancer pain in primary care. The study focuses on how this approach affects pain interference compared to usual care. The trial is conducted at eight healthcare centers in Region Uppsala, Sweden, involving pharmacists, general practitioners, physiotherapists, psychologists, and care managers. The treatment includes three phases over 24 weeks. Phase 1 (weeks 1-3) involves assessment visits with each healthcare professional to review medication, analyze pain, and evaluate physical and psychological factors. Phase 2 (weeks 3-4) is a team consultation with the patient to create a personalized rehabilitation plan. Phase 3 (weeks 4-24) implements this plan with regular follow-up phone contacts every 1 to 3 weeks and a second team consultation halfway through. Participants will be involved for 52 weeks total, including treatment and follow-up. Researchers will assess pain interference as the primary outcome after 6 months. Throughout the study, patients will undergo medication reviews, pain analyses, psychological and physical evaluations, and frequent follow-ups to monitor progress and adjust care. The study aims to find better ways to manage chronic pain and opioid use in primary care settings.